Latest Non-small cell lung carcinoma Stories
SEATTLE, May 20, 2015 /PRNewswire/ -- Resolution Bioscience announced today the successful results from their CLIA validation of ctDx
- Lead product candidate, VAL-083 for the treatment of glioblastoma multiforme (GBM), positioned to enter registration-directed Phase II/III clinical trials in 2H 2015 - VANCOUVER, British
- LUX-Lung 8 Phase III study evaluating the efficacy and safety of afatinib vs.
SAN DIEGO, May 13, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc.
New minimally invasive technology may help patients with lung cancer get earlier diagnoses and those with benign lesions avoid unnecessary invasive procedures. Wesley
PARIS, May 11, 2015 /PRNewswire/ -- OSE Pharma SA (ISIN: FR0012127173; Mnemo: OSE), a biotechnology company based in France, developing T specific immunotherapy treatments
Analysis concludes that use of Trovagene's urinary liquid biopsy significantly reduces costs when compared to tissue biopsy SAN DIEGO, May 4, 2015 /PRNewswire/ -- Trovagene, Inc.,
ROCKVILLE, Md., April 30, 2015 /PRNewswire-USNewswire/ -- Lung cancer impacts the lives of millions of people worldwide.
Protocol Amended to Provide Faster Assessment of Survival Outcomes with Reduced Trial Size BOTHELL, Wash.
- 60 percent of surveyed U.S.
- A woman chauffeur.
- A woman who operates an automobile.